Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT05185089 · COMPLETED
Trial details
- NCT number
- NCT05185089
- Sponsor
- Nerre Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-06-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.